The promising role of miR-296 in human cancer

被引:24
作者
Zhu, Lingling [1 ]
Deng, Hanyu [1 ]
Hu, Jia [1 ]
Huang, Shanshan [2 ]
Xiong, Jianping [2 ]
Deng, Jun [2 ]
机构
[1] Sichuan Univ, West China Hosp, Lung Canc Ctr, Chengdu, Sichuan, Peoples R China
[2] Nanchang Univ, Affiliated Hosp 1, Dept Oncol, Nanchang, Jiangxi, Peoples R China
基金
中国国家自然科学基金;
关键词
MiR-296; Cancer; Target genes; CELL LUNG-CANCER; ENDOTHELIAL GROWTH-FACTOR; MICRORNA EXPRESSION; BREAST-CANCER; HEPATOCELLULAR-CARCINOMA; DIFFERENTIAL EXPRESSION; GENE-EXPRESSION; TUMOR INVASION; GASTRIC-CANCER; PROLIFERATION;
D O I
10.1016/j.prp.2018.09.026
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
MicroRNAs (MiRNAs) are small non-protein-coding RNA molecules that silence mRNA translation; they have emerged as key players in nearly all biological processes in the past few decades. In particular, miRNAs are involved in carcinogenic processes, with either oncogenic or tumor suppressive roles in human cancers. The abnormal expression of miR-296 has important roles in various cellular processes inhuman malignancies, including cell proliferation, apoptosis, invasion, and epithelial-mesenchymal transition. Epigenetic mechanisms and upstream transcription factors are responsible for the regulation of miR-296 expression in cancer. In this review, we summarize and discuss the most recent findings regarding miR-296 in cancer, including its downstream targets, functional effects, underlying regulatory mechanisms, and therapeutic potentials.
引用
收藏
页码:1915 / 1922
页数:8
相关论文
共 112 条
[1]   Brain microRNAs and insights into biological functions and therapeutic potential of brain enriched miRNA-128 [J].
Adlakha, Yogita K. ;
Saini, Neeru .
MOLECULAR CANCER, 2014, 13
[2]   MiR-296-3p regulates cell growth and multi-drug resistance of human glioblastoma by targeting ether-a-go-go (EAG1) [J].
Bai, Yifeng ;
Liao, Hongzhan ;
Liu, Tianzhu ;
Zeng, Xiangping ;
Xiao, Faman ;
Luo, Luqiao ;
Guo, Hongbo ;
Guo, Linlang .
EUROPEAN JOURNAL OF CANCER, 2013, 49 (03) :710-724
[3]   MicroRNAs: Genomics, biogenesis, mechanism, and function (Reprinted from Cell, vol 116, pg 281-297, 2004) [J].
Bartel, David P. .
CELL, 2007, 131 (04) :11-29
[4]  
BECKER JC, 1991, J IMMUNOL, V147, P4398
[5]   First microRNA mimic enters clinic [J].
Bouchie, Aaron .
NATURE BIOTECHNOLOGY, 2013, 31 (07) :577-577
[6]   Shortcuts to a functional adipose tissue: The role of small non-coding RNAs [J].
Brandao, Bruna B. ;
Guerra, Beatriz A. ;
Mori, Marcelo A. .
REDOX BIOLOGY, 2017, 12 :82-102
[7]   MicroRNA signatures in human cancers [J].
Calin, George A. ;
Croce, Carlo M. .
NATURE REVIEWS CANCER, 2006, 6 (11) :857-866
[8]   Branching morphogenesis and antiangiogenesis candidates: tip cells lead the way [J].
Carmeliet, Peter ;
De Smet, Frederik ;
Loges, Sonja ;
Mazzone, Massimiliano .
NATURE REVIEWS CLINICAL ONCOLOGY, 2009, 6 (06) :315-326
[9]   Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis [J].
Chen, Zhen ;
Lai, Tsung-Ching ;
Jan, Yi-Hua ;
Lin, Feng-Mao ;
Wang, Wei-Chi ;
Xiao, Han ;
Wang, Yun-Ting ;
Sun, Wei ;
Cui, Xiaopei ;
Li, Ying-Shiuan ;
Fang, Tzan ;
Zhao, Hongwei ;
Padmanabhan, Chellappan ;
Sun, Ruobai ;
Wang, Danny Ling ;
Jin, Hailing ;
Chau, Gar-Yang ;
Huang, Hsien-Da ;
Hsiao, Michael ;
Shyy, John Y-J. .
JOURNAL OF CLINICAL INVESTIGATION, 2013, 123 (03) :1057-1067
[10]   Integrated microRNA-mRNA analyses of distinct expression profiles in follicular thyroid tumors [J].
Chi, Jiadong ;
Zheng, Xiangqian ;
Gao, Ming ;
Zhao, Jingzhu ;
Li, Dapeng ;
Li, Jiansen ;
Dong, Li ;
Ruan, Xianhui .
ONCOLOGY LETTERS, 2017, 14 (06) :7153-7160